What Happened?
San Mateo, AB-based Terns Pharmaceuticals Appointed Weidong Zhong as Founder and Chief Executive Officer
Date of management change: April 15, 2017
San Mateo, AB-based Terns Pharmaceuticals Appointed Weidong Zhong as Founder and Chief Executive Officer
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns` programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. Terns` investors include OrbiMed, Vivo Capital, Lilly Asia Ventures, and Decheng Capital.
Weidong Zhong is Founder and Chief Executive Officer at Terns Pharmaceuticals. Previously, Weidong held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: McCarthy John, Lewis Todd, Goetsch Kelly, Weber Mary, Wall Mandie, Lee Jason, Chamberlain Jim, Dalton Heather, Tsai Alexander, Sanchez Jonell, Strzemp John
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.